In addition, in cisplatin-resistant NSCLC cells, TATDN1 (Homo sapiens TatD DNase domain containing 1) lncRNA downregulated miR-451, which was overexpressed in these cells, and TATDN1 knockdown improved cisplatin sensitivity [68]. Here, TATDN1 is linked to non-small cell lung carcinoma.